Today: 7 Februar 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3t-pl- Page 177

MercadoLibre (MELI) Stock Today: Sharp Pullback, New Shelf Filing and Fresh Institutional Moves – 20 November 2025

MercadoLibre (MELI) Stock Today: Sharp Pullback, New Shelf Filing and Fresh Institutional Moves – 20 November 2025

MercadoLibre, Inc. (NASDAQ: MELI) is back in the spotlight today, 20 November 2025, as its share price slides sharply even while new filings show fresh institutional buying and a recently filed mixed shelf registration reshapes expectations for the Latin American e‑commerce giant’s next growth phase. Below is a breakdown of the key MercadoLibre news and market action specifically dated 20 November 2025, plus the broader context investors are watching. MercadoLibre stock on 20 November 2025: Pullback deepens near support After a strong multi‑year run, MELI stock is decisively on the back foot today. According to MarketScreener’s Nasdaq data, MercadoLibre shares
20 November 2025
·
Coca-Cola (KO) Stock: 7 Surprising Facts You Need to Know (Oct 11, 2025)

Coca-Cola Stock (KO) Today: Price, Fresh Analyst Calls and Key News on November 21, 2025

Published: November 21, 2025 – All figures as of market trading on this date. Coca-Cola stock today: near highs with fresh momentum Coca-Cola stock (NYSE: KO) is trading around $73 per share in Friday’s session, up roughly 2–2.5% from Thursday’s close of $71.21.StockAnalysis+1 That puts the beverage giant within touching distance of its 52‑week high of $74.38, and well above its 12‑month low of $60.62.StockAnalysis+1 Over the last year, Coca-Cola has delivered about 15% total shareholder return, including dividends, and is up just over 15% year to date, underscoring its role as a defensive winner in a choppy market.Simply Wall
21 November 2025
·
Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk stock is back in the spotlight today, 21 November 2025, as a cluster of breaking headlines hits the world’s most closely watched weight‑loss drug maker. As of late morning in New York, Novo Nordisk’s U.S. ADR (NYSE: NVO) is trading around $47.07, down roughly 1.1% on the day, giving the company a market value close to $213 billion. In Copenhagen, Novo Nordisk’s B‑shares finished the session around DKK 305, down nearly 3% and extending a steep slide that has left the stock down about 45% year‑to‑date. Investing.com+1 Today’s trading comes against a flurry of fresh news: Below is
21 November 2025
···
NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics stock is one of those tickers that still pops up on certain quote screens in late 2025 – but in reality, it isn’t a “normal” stock anymore. As of Sunday, November 23, 2025, NeuBase is a dissolved biotech in legal wind‑down, its common shares delisted and largely cashed out through liquidation payments and a non‑tradable escrow structure. MarketWatch+1 Below is a deep, investor‑focused look at what NBSE actually represents today, what happened in 2024–2025, and what, if anything, existing shareholders can still reasonably expect. Key takeaways for NBSE on November 23, 2025 Where NeuBase stands today (Sunday, November
23 November 2025
·
1 … 175 176 177

Stock Market Today

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

Kein IRS-Stimulus-Scheck über 2.000 Dollar kommt im Februar 2026 – aber Trumps Gerede über Zoll-Schecks hält die Gerüchte am Leben

7 Februar 2026
Für Februar 2026 sind keine neuen bundesweiten Stimulus-Schecks geplant, der IRS hat keine Ankündigung gemacht und der Kongress keine Zahlungen genehmigt. Trump prüft laut NBC $2.000 Tarif-Rabatt-Schecks, hat sich aber nicht festgelegt. Der IRS warnt vor Betrugsversuchen per SMS oder E-Mail. Social-Media-Gerüchte über neue Schecks halten an.
Salesforce stock tries to stabilize after AI “software-mageddon” — Feb. 25 earnings is the next test

Salesforce-Aktie versucht sich nach dem KI-„Software-Mageddon“ zu stabilisieren – Quartalszahlen am 25. Februar sind der nächste Test

7 Februar 2026
Salesforce-Aktien stiegen am Freitagvormittag um 0,1 % auf 190,07 $, nachdem sie diese Woche um 9 % gefallen waren. Der S&P 500 Software-Index verlor am Donnerstag 4,6 %. Investoren sorgen sich, dass neue KI-Tools wie Anthropic Claude Opus 4.6 traditionelle Softwareanbieter unter Druck setzen. Salesforce veröffentlicht Quartalszahlen am 25. Februar nach Börsenschluss.
Go toTop